EGFR and non-small cell lung carcinoma: In particular, Shi et al9 reported EGFR–sequence variation prevalence of up to 50% in patients in East Asia compared with 12.8% in Europe in the PIONEER project, which is a global epidemiological study focusing on EGFR sequence variations in patients with newly diagnosed advanced NSCLC in Asia.